Amlodipine Besylate Tablet
Product Images NDC 82009-026

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 82009-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of Amlodipine Besylate, a calcium channel blocker used as an oral tablet medication. The diagram shows the molecular arrangement including rings, chlorine, oxygen, nitrogen, and other atoms typical of amlodipine besylate's chemical composition.*

FDA Label Image

Fig-1 (Fig 1)

A Kaplan-Meier curve comparing event rates over 24 months between placebo and amlodipine groups. The graph shows a lower event rate for the amlodipine group compared to placebo, with statistical data including a P-value of 0.003 and a hazard ratio of 0.691 (95% CI: 0.54, 0.88). The x-axis represents time in months, and the y-axis represents event rate.*

FDA Label Image

Fig-2 (Fig 2)

A forest plot chart illustrating hazard ratios with 95% confidence intervals comparing Amlodipine and placebo across various subgroups including overall patients, age groups, gender, baseline sitting systolic blood pressure (SBP), baseline vessel disease status, vessel stenosis, and PCI-stent strata. The x-axis represents hazard ratio values from 0.0 to 2.0, with a vertical line indicating no effect at 1.0.*

FDA Label Image

Container-label-2pt5mg-90s (Container Label 2pt5mg 90s)

Label for Amlodipine Besylate Tablets, USP 2.5 mg by Quallent Pharmaceuticals Health LLC. The label states 90 tablets per package, with storage instructions, dosage form as oral tablets, and manufacturer details including Cipla Ltd. and Quallent Pharmaceuticals. It also includes a pharmacy dispense instruction and an NDC number 82009-026-90.*

FDA Label Image

Container-label-5mg-1000s (Container Label 5mg 1000s)

Label for Amlodipine Besylate Tablets, USP 5 mg, supplied in a package of 1000 tablets. The label shows it is Rx only and includes manufacturer information for Cipla Ltd., India, and Quallent Pharmaceuticals Health LLC, Grand Cayman. Storage instructions specify 20°C to 25°C. The label highlights pharmacist dispensing guidance and includes a barcode and revision date of 4/2024.*

FDA Label Image

Container-label-10mg-1000s (Container Label 10mg 1000s)

A label for Amlodipine Besylate Tablets, USP 10 mg, manufactured by Cipla Ltd. and labeled for Quallent Pharmaceuticals Health LLC. It indicates 1000 tablets per container, with storage instructions and dispensing information for pharmacists. The label includes a barcode and cautions to dispense with the patient leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.